587 related articles for article (PubMed ID: 9400788)
1. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
Arch Ophthalmol; 1997 Dec; 115(12):1545-52. PubMed ID: 9400788
[TBL] [Abstract][Full Text] [Related]
2. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.
Beck RW; Gal RL; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Moke PS; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Trobe JD; Wall M; Xing D;
Am J Ophthalmol; 2004 Jan; 137(1):77-83. PubMed ID: 14700647
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
[TBL] [Abstract][Full Text] [Related]
4. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial.
Cole SR; Beck RW; Moke PS; Gal RL; Long DT
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1017-21. PubMed ID: 10752936
[TBL] [Abstract][Full Text] [Related]
5. The SKILL Card test in optic neuritis: experience of the Optic Neuritis Treatment Trial. Smith-Kettlewell Institute Low Luminance. Optic Neuritis Study Group.
Long DT; Beck RW; Moke PS; Blair RC; Kip KE; Gal RL; Katz BJ
J Neuroophthalmol; 2001 Jun; 21(2):124-31. PubMed ID: 11450903
[TBL] [Abstract][Full Text] [Related]
6. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial.
Optic Neuritis Study Group
Ophthalmology; 2008 Jun; 115(6):1079-1082.e5. PubMed ID: 17976727
[TBL] [Abstract][Full Text] [Related]
7. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
[TBL] [Abstract][Full Text] [Related]
8. [Spatial contrast sensitivity in multiple sclerosis].
Vighetto A; Grochowicki M; Cousin J
Rev Neurol (Paris); 1990; 146(4):264-70. PubMed ID: 2359900
[TBL] [Abstract][Full Text] [Related]
9. Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial.
Moss HE; Gao W; Balcer LJ; Joslin CE
JAMA Ophthalmol; 2014 Apr; 132(4):421-7. PubMed ID: 24557028
[TBL] [Abstract][Full Text] [Related]
10. The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results.
Volpe NJ
Arch Ophthalmol; 2008 Jul; 126(7):996-9. PubMed ID: 18625952
[No Abstract] [Full Text] [Related]
11. Color vision defect type and spatial vision in the optic neuritis treatment trial.
Schneck ME; Haegerstrom-Portnoy G
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
[TBL] [Abstract][Full Text] [Related]
12. Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial.
Beck RW; Kupersmith MJ; Cleary PA; Katz B
Ophthalmology; 1993 May; 100(5):691-7; discussion 697-8. PubMed ID: 8493012
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis.
Menon V; Mehrotra A; Saxena R; Jaffery NF
Indian J Ophthalmol; 2007; 55(5):355-9. PubMed ID: 17699944
[TBL] [Abstract][Full Text] [Related]
14. Clinical profile of Malay children with optic neuritis.
Shatriah I; Adlina AR; Alshaarawi S; Wan-Hitam WH
Pediatr Neurol; 2012 May; 46(5):293-7. PubMed ID: 22520350
[TBL] [Abstract][Full Text] [Related]
15. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
Fisher JB; Jacobs DA; Markowitz CE; Galetta SL; Volpe NJ; Nano-Schiavi ML; Baier ML; Frohman EM; Winslow H; Frohman TC; Calabresi PA; Maguire MG; Cutter GR; Balcer LJ
Ophthalmology; 2006 Feb; 113(2):324-32. PubMed ID: 16406539
[TBL] [Abstract][Full Text] [Related]
16. Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial.
Cleary PA; Beck RW; Bourque LB; Backlund JC; Miskala PH
J Neuroophthalmol; 1997 Mar; 17(1):18-23; quiz 24-8. PubMed ID: 9093956
[TBL] [Abstract][Full Text] [Related]
17. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.
Keltner JL; Johnson CA; Cello KE; Dontchev M; Gal RL; Beck RW;
Arch Ophthalmol; 2010 Mar; 128(3):330-7. PubMed ID: 20212204
[TBL] [Abstract][Full Text] [Related]
18. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
Beck RW; Trobe JD; Moke PS; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Wall M;
Arch Ophthalmol; 2003 Jul; 121(7):944-9. PubMed ID: 12860795
[TBL] [Abstract][Full Text] [Related]
19. Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: a clinical case series.
Sethi HS; Menon V; Sharma P; Khokhar S; Tandon R
Indian J Ophthalmol; 2006 Sep; 54(3):177-83. PubMed ID: 16921215
[TBL] [Abstract][Full Text] [Related]
20. The Course of Visual Recovery after Optic Neuritis: Experience of the Optic Neuritis Treatment Trial.
Beck RW; Cleary PA; Backlund JC;
Ophthalmology; 2020 Apr; 127(4S):S174-S181. PubMed ID: 32200819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
